- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.02. | ENvue Medical receives patent allowance for feeding tube technology | 6 | Investing.com | ||
| 24.02. | ENvue Medical, Inc.: ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera | 6 | GlobeNewswire (USA) | ||
| 04.02. | Morning Market Movers: Silicon Laboratories, Concorde International Group, ENvue Medical, Enphase Energy See Big Swings | 453 | AFX News | SUNNYVALE (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 30.01. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 28.01. | ENvue Medical partners with U-Deliver to distribute ENFit syringes | 8 | Investing.com | ||
| 28.01. | ENvue Medical, Inc.: ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line | 8 | GlobeNewswire (USA) | ||
| 28.01. | EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal | 10 | Benzinga.com | ||
| 21.01. | ENvue Medical, Inc.: ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial | 4 | GlobeNewswire (USA) | ||
| 14.01. | ENvue Medical, Inc.: ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription | 5 | GlobeNewswire (USA) | ||
| 14.01. | EXCLUSIVE: Micro-Cap ENvue Medical Launches OTC Reusable Syringes For Feeding, Medication Delivery | 10 | Benzinga.com | ||
| 09.01. | ENvue Medical to develop vibration tech for nasogastric tube comfort | 2 | Investing.com | ||
| 09.01. | ENvue Medical, Inc.: ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research | 3 | GlobeNewswire (USA) | ||
| 08.01. | ENvue Medical, Inc.: ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 | 4 | GlobeNewswire (USA) | ||
| 30.12.25 | Envue Medical passt langfristigen Anreizplan an israelisches Steuerrecht an | 11 | Investing.com Deutsch | ||
| 23.12.25 | ENvue Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.25 | UK adds ENvue Medical's UroShield kit to NHS drug tariff | 3 | Investing.com | ||
| 18.12.25 | ENvue Medical, Inc.: ENvue Medical, Formerly NanoVibronix, UroShield Kit Secures Reimbursement in the UK | 2 | GlobeNewswire (USA) | ||
| 12.12.25 | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | 4 | FiercePharma | ||
| 12.12.25 | NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol | 3 | Investing.com | ||
| 12.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 36,550 | -1,19 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers mit einem Kursziel von 52,15 Euro auf "Outperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| BECTON DICKINSON | 133,40 | +0,15 % | Dividendenbekanntmachungen (10.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADAIRS LIMITED AU000000ADH2 0,055 AUD 0,0334 EUR ALCOA CORPORATION US0138721065 0,1 USD 0,0859 EUR AMEREN CORPORATION US0236081024 0... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | +5,00 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| SPINEWAY | 0,157 | +4,39 % | Spineway: 2025 annual results | Ecully, February 17, 2026 - 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 6,900 | +1,17 % | Lifeward Ltd.: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results | Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new... ► Artikel lesen | |
| NUWELLIS, INC | 0,960 | -4,00 % | Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results | MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| GLUCOTRACK | 1,040 | -2,80 % | Glucotrack, Inc.: Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization... ► Artikel lesen | |
| BONE BIOLOGICS | 1,180 | +1,72 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| MANGOCEUTICALS | 0,300 | -14,26 % | Mangoceuticals, Inc.: Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. | Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals," the "Company," or "MangoRx"), a company focused on developing, marketing, and selling health... ► Artikel lesen | |
| FRESENIUS | 43,690 | -1,82 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
16.03.2026 / 17:10... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | -1,38 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 21,600 | +21,76 % | Aktien KW 11 Aktienmärkte hoffen auf TACO-Trade. Je länger der dauert, … News. Porsche. Nordex. 3U Holding. Grenke. Mutares. Gabler. Masterflex. Deutsche Beteiligungs AG. Deutsche Rohstoff. Nordex. Gerresheimer | Aktien: Eine weitere Woche Bomben auf den Iran, keine erkennbaren "Erfolge" - ausser das sinnlos Menschen sterben. Und langsam kommt der amerikanische Angriff bei der Welt an. Steigende Ölpreise an... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,100 | -2,35 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,200 Euro und damit -0,83 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.